Indium-111-Photofrin-II Scintillation Scan
Authors:
- 1 April 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 24 (4) , 547-556
Abstract
Photodynamic therapy is under intense investigation as an adjuvant treatment for malignant glial tumors of the central nervous system. Photofrin-II (HKeywords
This publication has 10 references indexed in Scilit:
- Stereotactic Histologic Correlations of Computed Tomography- and Magnetic Resonance Imaging-Defined Abnormalities in Patients With Glial NeoplasmsMayo Clinic Proceedings, 1987
- A Histologic and Cytologic Method for the Spatial Definition of GliomasMayo Clinic Proceedings, 1987
- Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of actionBritish Journal of Cancer, 1986
- Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissueJournal of Neuro-Oncology, 1985
- Photoradiation therapy of 9L-gliosarcoma in rats: hematoporphyrin derivative (types I and II) followed by laser energyJournal of Neuro-Oncology, 1985
- ACTION SPECTRA FOR HEMATOPORPHYRIN DERIVATIVE AND PHOTOFRIN II WITH RESPECT TO SENSITIZATION OF HUMAN CELLSIN VITROTO PHOTOINACTIVATIONPhotochemistry and Photobiology, 1984
- A simple chemical method of labeling hematoporphyrin derivative with technetium‐99mJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- TISSUE DISTRIBUTION OF HEMATOPORPHYRIN-H-3 DERIVATIVE IN ATHYMIC NUDE-MICE HETEROTRANSPLANTED WITH HUMAN RETINOBLASTOMA1982
- Preparation of 109Pd-hematoporphyrin for selective lymphatic ablation using N-methylhematoporphyrinThe International Journal of Applied Radiation and Isotopes, 1981
- DETERMINATION OF [HEMATOPORPHYRIN-H-3] AND [HEMATOPORPHYRIN-C-14 DERIVATIVE DISTRIBUTION IN MALIGNANT AND NORMAL TISSUE1979